peptide elongation factor 2 has been researched along with pentostatin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreitman, RJ; Pastan, I | 1 |
1 review(s) available for peptide elongation factor 2 and pentostatin
| Article | Year |
|---|---|
Immunoconjugates in the management of hairy cell leukemia.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bacterial Toxins; Cladribine; Clinical Trials as Topic; Exotoxins; Humans; Immunoconjugates; Leukemia, Hairy Cell; Mutation; Neoplasm, Residual; Pentostatin; Peptide Elongation Factor 2; Proto-Oncogene Proteins B-raf; Remission Induction; Survival Analysis | 2015 |